The FDA National Center for Toxicological Research advances the scientific foundation for regulatory decision-making by conducting cutting-edge toxicological and biomedical research to ensure the safety of food, drugs, and medical products. Its core mission centers on understanding biological respon...
The FDA National Center for Toxicological Research advances the scientific foundation for regulatory decision-making by conducting cutting-edge toxicological and biomedical research to ensure the safety of food, drugs, and medical products. Its core mission centers on understanding biological responses to chemical and environmental agents, with strategic priorities in molecular toxicology, high-throughput screening, and translational biomarker discovery. Key programs focus on mechanistic studies of drug toxicity, reproductive and developmental effects, and the development of non-animal testing methodologies, leveraging advanced analytical platforms to support evidence-based regulation.
The agency procures a broad range of specialized laboratory instrumentation, precision equipment, and contract research services to sustain its experimental infrastructure. Procurements frequently target analytical instruments for genomics, proteomics, and metabolomics, alongside automated systems for tissue processing and animal care. Contracts are typically structured as combined or sources-sought solicitations, often requiring technical expertise in life sciences instrumentation, data analysis, and regulatory-compliant laboratory operations.
Primary procurement activity is concentrated in analytical laboratory instrument manufacturing, biotechnology research services, and testing laboratory support, reflecting its emphasis on high-precision, data-driven toxicology. The agency consistently prioritizes Small Business Administration (SBA) set-asides, indicating a strong commitment to partnering with innovative small firms capable of delivering specialized scientific and technical solutions. Vendor relationships are built around niche capabilities in life science tools, laboratory automation, and computational biology, with frequent engagement for custom instrumentation and service contracts requiring validated protocols.
As a research division within the Food and Drug Administration under the Department of Health and Human Services, the FDA National Center for Toxicological Research operates as a federal scientific hub with no fixed geographic footprint, supporting national regulatory science through distributed collaborations. It utilizes standard federal procurement vehicles, including indefinite-delivery/indefinite-quantity contracts and competitive solicitations, to acquire mission-critical research tools and scientific services essential to public health protection.
